NCT05259722 - A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema | Biotech Hunter

Enrollment

513

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

November 8, 2023

Study Completion Date

December 5, 2023

Conditions

Chronic Hand Eczema

Interventions

DRUG

Delgocitinib

Cream for topical application 20 mg/g

DRUG

Toctino

1 capsule toctino 30 mg per day; optional reduction to 10 mg per day in case unacceptable adverse reactions to the higher dose occur

Trial Locations (102)

4010

LEO Pharma Investigational Site, Linz

4011

LEO Pharma Investigational Site, Stavanger

4019

LEO Pharma Investigational Site, Terracina

4021

LEO Pharma Investigational Site, Linz

6202

LEO Pharma investigational site, Nice

8036

LEO Pharma Investigational Site, Graz

9038

LEO Pharma Investigational Site, Tromsø

10789

LEO Pharma Investigational Site, Berlin

13055

LEO Pharma Investigational Site, Berlin

13500

LEO Pharma Investigational Site, Martigues

14004

LEO Pharma Investigational Site, Córdoba

16132

LEO Pharma Investigational Site, Genova

20089

LEO Pharma Investigational Site, Milan

22391

LEO Pharma Investigational Site, Hamburg

25123

LEO Pharma Investigational Site, Brescia

26133

LEO Pharma Investigational Site, Oldenburg

27100

LEO Pharma Investigational Site, Pavia

28006

LEO Pharma Investigational Site, Madrid

28034

LEO Pharma Investigational Site, Madrid

28040

LEO Pharma Investigational Site, Madrid

28041

LEO Pharma Investigational Site, Madrid

28805

LEO Pharma Investigational Site, Alcalá de Henares

29009

LEO Pharma investigational site, Málaga

34295

LEO Pharma Investigational Site, Montpellier

35043

LEO Pharma Investigational Site, Marburg

36071

LEO Pharma investigational site, Pontevedra

37075

LEO Pharma Investigational Site, Göttingen

40138

LEO Pharma Investigational Site, Bologna

41009

LEO Pharma Investigational Site, Seville

42287

LEO Pharma Investigational Site, Wuppertal

44791

LEO Pharma Investigational Site, Bochum

44793

LEO Pharma Investigational Site, Bochum

45147

LEO Pharma Investigational Site, Essen

46014

LEO Pharma Investigational Site, Valencia

46026

LEO Pharma Investigational Site, Valencia

49074

LEO Pharma Investigational Site, Osnabrück

49393

LEO Pharma Investigational Site, Löhne

50009

LEO Pharma Investigational Site, Zaragoza

51100

LEO Pharma Investigational Site, Reims

53111

LEO Pharma Investigational Site, Bonn

55100

LEO Pharma Investigational Site, Lucca

55131

LEO Pharma Investigational Site, Mainz

56126

LEO Pharma Investigational Site, Pisa

60590

LEO Pharma Investigational Site, Frankfurt

64283

LEO Pharma Investigational Site, Darmstadt

69120

LEO Pharma Investigational Site, Heidelberg

80337

LEO Pharma Investigational Site, München

80802

LEO Pharma Investigational Site, München

83000

LEO Pharma Investigational Site, Toulon

86163

LEO Pharma Investigational Site, Augsburg

87700

LEO Pharma Investigational Site, Memmingen

88045

LEO Pharma Investigational Site, Friedrichshafen

88100

LEO Pharma Investigational Site, Catanzaro

89129

LEO Pharma Investigational Site, Langenau

91054

LEO Pharma Investigational Site, Erlangen

92160

LEO Pharma Investigational Site, Antony

95123

LEO Pharma Investigational Site, Catania

T2J 7E1

LEO Pharma Investigational Site, Calgary

T2W 4X9

LEO Pharma Investigational Site, Calgary

T6G 1C3

LEO Pharma Investigational Site, Edmonton

T6W0J5

LEO Pharma Investigational Site, Edmonton

N1L 0B7

LEO Pharma Investigational Site, Guelph

N6A 2C2

LEO Pharma Investigational Site, London

N6A 5R9

LEO Pharma investigational site, London

L3P 1X3

LEO Pharma investigational site, Markham

L2H 1H5

LEO Pharma investigational site, Niagara Falls

M2N 3A6

LEO Pharma Investigational Site, North York

G1W 4R4

LEO Pharma investigational site, Québec

T4P 1K4

LEO Pharma Investigational Site, Red Deer

J1G 1X9

LEO Pharma investigational site, Sherbrooke

06000

LEO Pharma Investigational Site, Nice

01307

LEO Pharma Investigational Site, Dresden

07548

LEO Pharma Investigational Site, Gera

06110

LEO Pharma Investigational Site, Halle

15-794

LEO Pharma Investigational Site, Bialystok

85-796

LEO Pharma investigational site, Bydgoszcz

41-500

LEO Pharma Investigational Site, Chorzów

80-546

LEO Pharma Investigational Site, Gdansk

81-338

LEO Pharma Investigational Site, Gdynia

40-081

LEO Pharma Investigational Site, Katowice

40-611

LEO Pharma investigational site, Katowice

40-851

LEO Pharma investigational site, Katowice

30-033

LEO Pharma Investigational Site, Krakow

30-727

LEO Pharma Investigational Site, Krakow

31-501

LEO Pharma Investigational Site, Krakow

90-436

LEO Pharma Investigational Site, Lodz

20-080

LEO Pharma Investigational Site, Lublin

61-731

LEO Pharma Investigational Site, Poznan

47-100

LEO Pharma Investigational Site, Strzelce Opolskie

71-434

LEO Pharma Investigational Site, Szczecin

02-677

LEO Pharma Investigational Site, Warsaw

51-685

LEO Pharma Investigational Site, Wroclaw

851 01

LEO Pharma Investigational Site, Bratislava

089 01

LEO Pharma Investigational Site, Svidník

917 75

LEO Pharma Investigational Site, Trnava

03010

LEO Pharma Investigational Site, Alicante

08916

LEO Pharma Investigational Site, Badalona

08003

LEO Pharma Investigational Site, Barcelona

08025

LEO Pharma Investigational Site, Barcelona

08907

LEO Pharma Investigational Site, L'Hospitalet de Llobregat

SE1 9RT

LEO Pharma Investigational Site, London

NG7 2UH

LEO Pharma Investigational Site, Nottingham